VERVE THERAPEUTICS INC (VERV) Stock Cash Flow
NASDAQ:VERV - Nasdaq - US92539P1012 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -181.01M | -198.71M | -200.07M | -157.39M | -120.31M | |||
| Depreciation Amortization | 6.84M | 6.75M | 5.46M | 2.80M | 1.54M | |||
| Change In Working Capital | -7.67M | -2.26M | 17.70M | 8.38M | -2.91M | |||
| Other non cash items | 39.38M | 36.52M | 27.36M | 23.87M | 43.81M | |||
| OPERATING CASH FLOW | -142.46M | -157.69M | -149.55M | -122.33M | -77.88M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -4.53M | -3.74M | -9.28M | -13.23M | -4.36M | |||
| Other Investing Activity | 72.87M | 78.61M | 36.97M | -142.72M | -234.74M | |||
| INVESTING CASH FLOW | 68.34M | 74.88M | 27.69M | -155.96M | -239.10M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | 26.48M | 49.26M | 213.03M | 329.74M | 379.94M | |||
| Other Financing Activity | N/A | -66.00K | -458.00K | -780.00K | -2.85M | |||
| FINANCING CASH FLOW | 26.47M | 49.20M | 212.58M | 328.96M | 377.09M | |||
| CHANGE IN CASH | -47.65M | -33.62M | 90.72M | 50.67M | 60.11M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -142.46M | -157.69M | -149.55M | -122.33M | -77.88M | |||
| Capital Expenditure | -4.53M | -3.74M | -9.28M | -13.23M | -4.36M | |||
| FREE CASH FLOW | -146.98M | -161.43M | -158.83M | -135.56M | -82.24M | |||
All data in USD